News – Page 32 – Endpoints News

Pfizer terminates an early-stage STING agonist trial

2 months ago

MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy

2 months ago

With Hinge Health filing to go public, are we... back?

2 months ago

Acelyrin, Pliant turn to ‘poison pill’ as Kevin Tang’s Concentra pursues both companies

2 months ago

Canada pitches in to Entos' facility build; Vetter expands in Germany

2 months ago

Updated: White House pulls Weldon's nomination to lead CDC at last minute

2 months ago

Inside NYC’s waitlist-only health tech club, where young professionals find both friends and jobs

2 months ago

Endpoints wins SABEW 'Best in Business' award for Health Tech coverage and newsletter

2 months ago

The new CEO of GoodRx wants to lean into brand names and speed up the drug discount company's growth

2 months ago

Montara Therapeutics adds $20M to seed fundraise for neurology pipeline

2 months ago

Amgen reports more Uplizna data in myasthenia gravis ahead of FDA filing

2 months ago

Updated: Endo and Mallinckrodt to merge in $6.7B deal

2 months ago

Mallinckrodt and Endo exploring a $7B merger — report

2 months ago

Researchers make case against Gilead in HIV product hopping fight

2 months ago

#CROI25: Merck’s troubled HIV drug heads to regulators; ViiV seeks longer-acting HIV treatment

2 months ago

Ascletis’ not-so-great weight loss data; Vivace’s $35M Series D

2 months ago

Insilico nabs $110M Series E for AI drug discovery after stalling Hong Kong IPO plans

2 months ago

Viking Therapeutics taps CordenPharma to manufacture its obesity drugs

2 months ago

Legend to double Carvykti production as it targets blockbuster status

2 months ago

Ono licenses rare blood disease drug from Ionis for $280M upfront

2 months ago

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

2 months ago

FDA’s medical review departments remain untouched (for now) by Musk’s cuts

2 months ago

Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’

2 months ago

Gilead plans to skip from Phase 1 to Phase 3 with once-yearly HIV prevention drug

2 months ago

First page Previous page 29 30 313233 34 35 Next page Last page